MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis

Keyphrases

• Proteinuria 100%
• Glomerulonephritis 100%
• Size Selectivity 100%
• Glomerular Size 100%
• Albumin 50%
• Leukotriene Biosynthesis 50%
• Glomerular Filtration Rate 25%
• No Adverse Effect 25%
• Adult Patients 25%
• Renal Insufficiency 25%
• Arachidonic Acid 25%
• Nephritis 25%
• Twice a Day 25%
• Hemodynamic Changes 25%
• Structural Change 25%
• Specific Action 25%
• Excretion Rate 25%
• Glomerular Function 25%
• Short-term Treatment 25%
• IgA Nephropathy (IgAN) 25%
• Protein Trafficking 25%
• Orally Active 25%
• Leukotriene B4 (LTB4) 25%
• Short-term Effects 25%
• C1q Deficiency 25%
• Glomerular Hemodynamics 25%
• Membranoproliferative 25%

Medicine and Dentistry

• Proteinuria 100%
• Glomerulonephritis 100%
• Leukotriene 100%
• Dextran 66%
• Adverse Event 33%
• Arachidonic Acid 33%
• Hemodynamic 33%
• Glomerular Filtration Rate 33%
• Metabolite 33%
• Nephritic Syndrome 33%
• Arachidonate 5 Lipoxygenase Activating Protein Inhibitor 33%
• Immunoglobulin A Nephropathy 33%
• Patient with Glomerulonephritis 33%
• Complement Component C1q 33%
• Arachidonate 5 Lipoxygenase Activating Protein 33%
• Short Course Therapy 33%
• Protein Targeting 33%
• Moderate Renal Impairment 33%